Eagle Pharmaceuticals, Inc. (EGRX)
Total Valuation
EGRX has a market cap or net worth of $64.53 million. The enterprise value is $119.37 million.
Market Cap | 64.53M |
Enterprise Value | 119.37M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
EGRX has 12.99 million shares outstanding. The number of shares has increased by 2.48% in one year.
Shares Outstanding | 12.99M |
Shares Change (YoY) | +2.48% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 12.02% |
Owned by Institutions (%) | 86.36% |
Float | 10.39M |
Valuation Ratios
The trailing PE ratio is 5.74 and the forward PE ratio is 1.31. EGRX's PEG ratio is 0.91.
PE Ratio | 5.74 |
Forward PE | 1.31 |
PS Ratio | 0.25 |
Forward PS | 0.26 |
PB Ratio | 0.26 |
P/FCF Ratio | n/a |
PEG Ratio | 0.91 |
Enterprise Valuation
EV / Earnings | 9.99 |
EV / Sales | 0.46 |
EV / EBITDA | 2.09 |
EV / EBIT | 3.39 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 0.28.
Current Ratio | 2.16 |
Quick Ratio | 1.51 |
Debt / Equity | 0.28 |
Debt / EBITDA | 1.23 |
Debt / FCF | n/a |
Interest Coverage | 5.79 |
Financial Efficiency
Return on equity (ROE) is 5.00% and return on invested capital (ROIC) is 5.21%.
Return on Equity (ROE) | 5.00% |
Return on Assets (ROA) | 3.00% |
Return on Capital (ROIC) | 5.21% |
Revenue Per Employee | $1.92M |
Profits Per Employee | $89,164 |
Employee Count | 134 |
Asset Turnover | 0.64 |
Inventory Turnover | 1.55 |
Taxes
In the past 12 months, EGRX has paid $17.22 million in taxes.
Income Tax | 17.22M |
Effective Tax Rate | 59.04% |
Stock Price Statistics
The stock price has decreased by -81.40% in the last 52 weeks. The beta is 0.43, so EGRX's price volatility has been lower than the market average.
Beta (1Y) | 0.43 |
52-Week Price Change | -81.40% |
50-Day Moving Average | 5.63 |
200-Day Moving Average | 11.71 |
Relative Strength Index (RSI) | 42.63 |
Average Volume (30 Days) | 234,724 |
Short Selling Information
The latest short interest is 1.16 million, so 8.95% of the outstanding shares have been sold short.
Short Interest | 1.16M |
Short Previous Month | 1.11M |
Short % of Shares Out | 8.95% |
Short % of Float | 11.20% |
Short Ratio (days to cover) | 4.56 |
Income Statement
In the last 12 months, EGRX had revenue of $257.55 million and earned $11.95 million in profits. Earnings per share was $0.91.
Revenue | 257.55M |
Gross Profit | 179.88M |
Operating Income | 41.01M |
Pretax Income | 29.17M |
Net Income | 11.95M |
EBITDA | 57.18M |
EBIT | 35.26M |
Earnings Per Share (EPS) | $0.91 |
Balance Sheet
The company has $15.35 million in cash and $70.19 million in debt, giving a net cash position of -$54.84 million or -$4.22 per share.
Cash & Cash Equivalents | 15.35M |
Total Debt | 70.19M |
Net Cash | -54.84M |
Net Cash Per Share | -$4.22 |
Equity / Book Value | 252.04M |
Book Value Per Share | 19.41 |
Working Capital | 100.62M |
Cash Flow
In the last 12 months, operating cash flow was -$9.32 million and capital expenditures -$74,000, giving a free cash flow of -$9.39 million.
Operating Cash Flow | -9.32M |
Capital Expenditures | -74,000 |
Free Cash Flow | -9.39M |
FCF Per Share | -$0.72 |
Margins
Gross margin is 69.84%, with operating and profit margins of 15.92% and 4.64%.
Gross Margin | 69.84% |
Operating Margin | 15.92% |
Pretax Margin | 11.33% |
Profit Margin | 4.64% |
EBITDA Margin | 22.20% |
EBIT Margin | 13.69% |
FCF Margin | -3.65% |
Dividends & Yields
EGRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.48% |
Shareholder Yield | -2.48% |
Earnings Yield | 18.51% |
FCF Yield | -14.55% |
Analyst Forecast
The average price target for EGRX is $17.00, which is 224.43% higher than the current price. The consensus rating is "Sell".
Price Target | $17.00 |
Price Target Difference | 224.43% |
Analyst Consensus | Sell |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
EGRX has an Altman Z-Score of 1.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.9 |
Piotroski F-Score | 3 |